The DLEU1 Polyclonal Antibody (PACO08852) is a valuable tool for researchers studying the DLEU1 gene, which is associated with cancer development and progression. This antibody, generated in rabbits, exhibits high specificity and sensitivity for detecting DLEU1 protein in human samples, making it suitable for use in Western blot applications. By targeting the DLEU1 protein, researchers can investigate its role in cancer biology and potentially identify new therapeutic targets for cancer treatment.DLEU1, a long non-coding RNA, has been implicated in various types of cancer, including leukemia, lymphoma, and solid tumors. Its dysregulation can promote tumor growth and metastasis, making it a promising biomarker for cancer diagnosis and prognosis.
By studying the function of DLEU1, researchers can gain insights into the mechanisms driving oncogenesis and potentially develop novel strategies for cancer therapy.Overall, the DLEU1 Polyclonal Antibody (PACO08852) offers researchers a reliable tool for studying the role of DLEU1 in cancer development and progression. Its high specificity and sensitivity make it an essential component of any cancer research project aiming to understand the molecular mechanisms underlying tumor formation and progression.
